Europe's flagship critical minerals policy has been in place for two years. Here's how ASX explorers say it can bring ...
Peregrine Gold (ASX:PGD) is preparing to undertake an expanded bulk sampling program over gold-bearing palaeogravels at its ...
RNU (ASX:RNU) has strengthened the drill case at Flat Hill after a high-resolution VTEM survey lit up multiple conductive ...
Sprott sees a new uranium contracting cycle emerging, creating opportunities for a fresh wave of ASX producers, developers ...
These whites are made for spring but experts claim a touch of Radiohead with your riesling heightens your sensory pleasure.
Pivotal Metals (ASX:PVT) has refined its Shanty Lake copper-nickel target at the Belleterre Project in Quebec after drill hole 26-PIV-08 missed mineralisation, with a downhole EM survey revealing a ...
The Calmer Co's Zane Yoshida believes Kava is finally having its moment with several tailwinds spearheading its long-term growth.
Rejection of Echo IQ’s clearance submission for its heart failure detection device, EchoSolv HF, will prove time is money.
The ASX sank this morning as oil and bond yields jumped, while MAAS, NRW and BHP kept the company news flowing.
Paradigm Biopharma shares today moved from trading halt to suspension after the company delayed releasing phase III knee pain ...
Dementia is Australia’s leading cause of death. ASX healthcare companies are among those searching for better ways to detect ...
Paradigm's long-awaited phase III knee osteo study has failed an interim 'futility' test - and the company is struggling for answers.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results